The Travelers Companies, Inc. (TRV) 10-Year Financial Performance & Capital Metrics

TRV • • Insurance & Managed Care

Financial ServicesProperty & Casualty InsuranceCommercial Lines InsuranceDiversified Commercial Lines

AboutThe Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally. The company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.Show more

Revenue $46.43B +12.2%
Combined Ratio 86.69% -5.6%
Net Income $5B +67.1%
Return on Equity 18.94% +47.2%
Medical Cost Ratio 73.3% -6.5%
Operating Margin 13.31% +63.4%
Net Margin 10.77% +48.9%
ROA 3.86% +55.9%
Equity / Assets 20.92% +5.8%
Book Value per Share 120.57 +12.3%
Tangible BV/Share 100.70 +13.1%
Debt/Equity 0.29 -10.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 86.7% combined ratio
✓Strong Piotroski F-Score: 9/9
✓19 consecutive years of dividend growth

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y5.5%

5Y8.01%

3Y10.07%

TTM6.74%

Profit (Net Income) CAGR

10Y3.08%

5Y13.78%

3Y10.93%

TTM29.3%

EPS CAGR

10Y7.21%

5Y16.7%

3Y14%

TTM30.41%

ROCE

10Y Avg3.58%

5Y Avg3.53%

3Y Avg3.58%

Latest4.92%

Peer Comparison

Diversified Commercial Lines

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SIGISelective Insurance Group, Inc.	5.01B	82.97	25.69	14.87%	7.78%	11.65%	21.33%	0.16
LLoews Corporation	21.32B	103.16	16.09	9.96%	8.07%	7.55%	11.22%	0.50
WRBW. R. Berkley Corporation	26.11B	68.71	15.76	12.32%	13.01%	19.44%	13.68%	0.34
THGThe Hanover Insurance Group, Inc.	6.05B	170.15	14.54	4.25%	9.75%	18.44%	13.15%	0.28
CBChubb Limited	118.5B	301.11	13.26	12%	16.48%	12.43%	13.66%	0.22
CNACNA Financial Corporation	12.56B	46.42	13.19	6.66%	6.84%	8.81%	19.71%	0.28
TRVThe Travelers Companies, Inc.	60.53B	271.34	12.64	12.22%	12.13%	18.58%	14.99%	0.29
AFGAmerican Financial Group, Inc.	11B	131.90	12.48	7.12%	9.7%	16.87%	10.47%	0.33

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	26.82B	27.63B	28.9B	30.28B	31.58B	31.98B	34.82B	36.9B	41.37B	46.43B
Revenue Growth %	-0.01%	0.03%	0.05%	0.05%	0.04%	0.01%	0.09%	0.06%	0.12%	0.12%
Medical Costs & Claims+	17.61B	19.05B	21.63B	22.67B	23.73B	23.9B	25.34B	28.37B	32.44B	34.03B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	9.21B	8.57B	7.27B	7.61B	7.85B	8.09B	9.47B	8.53B	8.93B	12.4B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.02%	-0.07%	-0.15%	0.05%	0.03%	0.03%	0.17%	-0.1%	0.05%	0.39%
Operating Expenses+	4.47B	4.52B	4.54B	4.65B	4.71B	4.85B	5.02B	5.17B	5.56B	6.22B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	818M	826M	813M	803M	763M	789M	870M	826M	722M	715M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	4.74B	4.05B	2.73B	2.96B	3.14B	3.24B	4.46B	3.35B	3.37B	6.18B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.07%	-0.14%	-0.33%	0.08%	0.06%	0.03%	0.38%	-0.25%	0.01%	0.83%
EBITDA+	5.56B	4.88B	3.54B	3.76B	3.9B	4.03B	5.33B	4.18B	4.09B	6.89B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	373M	363M	369M	352M	344M	339M	340M	351M	376M	392M
Non-Operating Income	-373M	-363M	-369M	-352M	-344M	-339M	-340M	-351M	-376M	-392M
Pretax Income+	4.74B	4.05B	2.73B	2.96B	3.14B	3.24B	4.46B	3.35B	3.37B	6.18B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	1.3B	1.04B	674M	438M	516M	540M	796M	512M	380M	1.18B
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	3.44B	3.01B	2.06B	2.52B	2.62B	2.7B	3.66B	2.84B	2.99B	5B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.07%	-0.12%	-0.32%	0.23%	0.04%	0.03%	0.36%	-0.22%	0.05%	0.67%
EPS (Diluted)+	10.88	10.28	7.33	9.35	9.92	10.52	14.49	11.77	12.79	21.47
EPS Growth %	0.02%	-0.06%	-0.29%	0.28%	0.06%	0.06%	0.38%	-0.19%	0.09%	0.68%
EPS (Basic)	10.99	10.39	7.39	9.44	10.01	10.56	14.63	11.91	12.93	21.76
Diluted Shares Outstanding	313.9M	291M	278.6M	269.8M	262.3M	254.6M	250.8M	239.7M	232.2M	231.1M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	100.18B	100.25B	103.48B	104.23B	110.12B	116.76B	120.47B	115.72B	125.98B	133.19B
Asset Growth %	-0.03%	0%	0.03%	0.01%	0.06%	0.06%	0.03%	-0.04%	0.09%	0.06%
Total Investment Assets+	70.47B	70.49B	72.5B	72.28B	77.88B	84.42B	87.38B	80.45B	88.81B	177.55B
Long-Term Investments	66.03B	66.11B	68.04B	67.82B	73.5B	80B	82.54B	75.44B	83.55B	89.12B
Short-Term Investments	65.33B	65.38B	67.59B	67.45B	73.08B	79.51B	81.65B	74.63B	82.94B	88.43B
Total Current Assets+	86.09B	85.89B	88.71B	89.06B	95B	101.43B	103.74B	97.02B	106.42B	112.61B
Cash & Equivalents	380M	307M	344M	373M	494M	721M	761M	799M	650M	699M
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	0	0	0	0	0	0
Goodwill & Intangibles+	3.85B	3.85B	4.29B	4.28B	4.29B	4.29B	4.31B	4.24B	4.25B	4.59B
Goodwill	3.57B	3.58B	3.95B	3.94B	3.96B	3.98B	4.01B	3.95B	3.98B	4.23B
Intangible Assets	279M	268M	342M	345M	330M	317M	306M	287M	277M	360M
PP&E (Net)	0	0	0	0	0	0	0	0	0	0
Other Assets	75.28B	75.42B	78B	77.89B	83.91B	90.56B	94.06B	87.21B	96.75B	-74.9B
Total Liabilities	76.59B	77.02B	79.75B	81.34B	84.18B	87.56B	91.58B	94.16B	101.06B	105.33B
Total Debt+	6.34B	6.44B	6.57B	6.56B	7.16B	6.55B	7.29B	7.29B	8.03B	8.03B
Net Debt	5.96B	6.13B	6.23B	6.19B	6.66B	5.83B	6.53B	6.49B	7.38B	7.33B
Long-Term Debt	5.84B	5.89B	5.97B	5.96B	6.56B	6.55B	7.19B	7.19B	7.93B	7.93B
Short-Term Debt	500M	550M	600M	600M	600M	0	100M	100M	100M	100M
Total Current Liabilities+	5.17B	5.43B	5.65B	5.67B	5.58B	4.62B	4.39B	4.12B	3.89B	3.84B
Accounts Payable	4.67B	4.88B	5.05B	5.07B	4.98B	4.62B	4.29B	4.01B	3.79B	3.74B
Deferred Revenue	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	1000K	1000K	1000K	0	0	0
Other Liabilities	65.57B	65.7B	68.13B	69.7B	71.9B	75.84B	79.7B	82.85B	89.24B	93.55B
Total Equity+	23.6B	23.22B	23.73B	22.89B	25.94B	29.2B	28.89B	21.56B	24.92B	27.86B
Equity Growth %	-0.05%	-0.02%	0.02%	-0.04%	0.13%	0.13%	-0.01%	-0.25%	0.16%	0.12%
Shareholders Equity	23.6B	23.22B	23.73B	22.89B	25.94B	29.2B	28.89B	21.56B	24.92B	27.86B
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	29.95B	32.2B	33.46B	35.2B	36.98B	38.77B	41.55B	43.52B	45.59B	49.63B
Common Stock	22.17B	22.61B	22.89B	23.14B	23.47B	23.74B	24.15B	24.57B	24.91B	25.45B
Accumulated OCI	-157M	-755M	-343M	-1.86B	640M	2.5B	1.19B	-6.45B	-4.47B	-4.97B
Return on Equity (ROE)	0.14%	0.13%	0.09%	0.11%	0.11%	0.1%	0.13%	0.11%	0.13%	0.19%
Return on Assets (ROA)	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.04%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.27x	0.28x	0.28x	0.29x	0.28x	0.22x	0.25x	0.34x	0.32x	0.29x
Book Value per Share	75.18	79.80	85.18	84.86	98.91	114.69	115.18	89.95	107.33	120.57
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.43B	4.47B	4.15B	4.38B	5.21B	6.52B	7.27B	6.46B	7.71B	9.07B
Operating CF Growth %	-0.07%	0.3%	-0.07%	0.06%	0.19%	0.25%	0.12%	-0.11%	0.19%	0.18%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	3.44B	3.01B	2.06B	2.52B	2.62B	2.7B	3.66B	2.84B	2.99B	5B
Depreciation & Amortization	818M	826M	813M	803M	763M	789M	870M	826M	722M	715M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	117M	110M	337M	-13M	-33M	-29M	62M	-186M	-163M	-152M
Other Non-Cash Items	3.66B	3.69B	3.55B	3.9B	4.24B	4.77B	4.63B	5.43B	6.82B	7.26B
Working Capital Changes	-4.6B	-3.17B	-2.61B	-2.83B	-2.38B	-1.71B	-1.95B	-2.44B	-2.66B	-3.75B
Cash from Investing+	317M	-1.73B	-2.2B	-2.33B	-2.9B	-4.89B	-5.2B	-3.73B	-6.82B	-7.26B
Capital Expenditures	0	0	0	0	0	0	0	0	0	0
Acquisitions	-13M	0	-439M	-4M	0	0	-38M	-4M	0	-382M
Purchase of Investments	-13.11B	-12.46B	-13.32B	-13.33B	-12.26B	-15.29B	-19.1B	-16.62B	-18.04B	-17.65B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-396M	-317M	-277M	-318M	-432M	-443M	-276M	-416M	-529M	-392M
Cash from Financing+	-3.73B	-2.81B	-1.92B	-2.01B	-2.19B	-1.42B	-2.04B	-2.67B	-1.05B	-1.75B
Dividends Paid	-739M	-757M	-785M	-814M	-844M	-861M	-869M	-875M	-908M	-951M
Share Repurchases	-3.22B	-2.47B	-1.44B	-1.32B	-1.55B	-672M	-2.2B	-2.06B	-1.02B	-1.12B
Stock Issued	0	0	0	0	0	0	0	0	0	0
Debt Issuance (Net)	-1000K	1000K	1000K	-1000K	-1000K	-1000K	1000K	0	1000K	0
Other Financing	238M	332M	173M	132M	213M	127M	293M	267M	141M	321M
Net Change in Cash+	6M	-73M	37M	29M	121M	227M	40M	38M	-149M	49M
Exchange Rate Effect	-1000K	-1000K	1000K	-1000K	1000K	1000K	-1000K	-1000K	1000K	-1000K
Cash at Beginning	374M	380M	307M	344M	373M	494M	721M	761M	799M	650M
Cash at End	380M	307M	344M	373M	494M	721M	761M	799M	650M	699M
Free Cash Flow+	3.43B	4.47B	4.15B	4.38B	5.21B	6.52B	7.27B	6.46B	7.71B	9.07B
FCF Growth %	-0.07%	0.3%	-0.07%	0.06%	0.19%	0.25%	0.12%	-0.11%	0.19%	0.18%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	10.94	15.36	14.89	16.23	19.84	25.6	29	26.97	33.21	39.26

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	82.32%	85.33%	90.55%	90.22%	90.06%	89.88%	87.2%	90.91%	91.85%	86.69%
Medical Cost Ratio	65.66%	68.98%	74.85%	74.87%	75.15%	74.72%	72.79%	76.89%	78.41%	73.3%
Return on Equity (ROE)	14.2%	12.88%	8.76%	10.82%	10.74%	9.78%	12.61%	11.27%	12.87%	18.94%
Return on Assets (ROA)	3.38%	3.01%	2.02%	2.43%	2.45%	2.38%	3.09%	2.41%	2.48%	3.86%
Equity / Assets	23.55%	23.16%	22.93%	21.96%	23.56%	25.01%	23.98%	18.63%	19.78%	20.92%
Book Value / Share	75.18	79.8	85.18	84.86	98.91	114.69	115.18	89.95	107.33	120.57
Debt / Equity	0.27x	0.28x	0.28x	0.29x	0.28x	0.22x	0.25x	0.34x	0.32x	0.29x
Revenue Growth	-1.32%	3.02%	4.62%	4.77%	4.29%	1.27%	8.86%	5.97%	12.13%	12.22%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Business Insurance	14.72B	15.3B	15.29B	15.73B	19.59B	21.86B	24.66B
Business Insurance Growth	-	3.93%	-0.04%	2.88%	24.50%	11.60%	12.79%
Personal Insurance	9.92B	10.41B	10.93B	11.98B	13.8B	15.6B	17.42B
Personal Insurance Growth	-	4.94%	5.00%	9.66%	15.19%	13.02%	11.65%
Bond & Specialty Insurance	2.42B	2.56B	2.82B	3.14B	3.7B	4.01B	4.38B
Bond & Specialty Insurance Growth	-	5.99%	10.06%	11.16%	17.78%	8.44%	9.23%

Revenue by Geography

	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	28.42B	29.64B	30.12B	32.6B	34.82B	39.09B	43.92B
UNITED STATES Growth	-	4.29%	1.64%	8.21%	6.83%	12.25%	12.38%
Non-US	1.86B	1.94B	1.86B	2.22B	2.06B	2.28B	2.5B
Non-US Growth	-	4.24%	-4.37%	19.48%	-7.12%	10.48%	9.70%
CANADA	1.29B	1.37B	1.28B	1.35B	1.3B	1.28B	1.36B
CANADA Growth	-	6.03%	-6.78%	5.71%	-3.77%	-1.46%	6.09%
Other Non-U.S.	571M	572M	580M	869M	762M	997M	1.14B
Other Non-U.S. Growth	-	0.18%	1.40%	49.83%	-12.31%	30.84%	14.34%

Frequently Asked Questions

Valuation & Price

The Travelers Companies, Inc. (TRV) has a price-to-earnings (P/E) ratio of 12.6x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

The Travelers Companies, Inc. (TRV) grew revenue by 12.2% over the past year. This is steady growth.

Yes, The Travelers Companies, Inc. (TRV) is profitable, generating $5.87B in net income for fiscal year 2024 (10.8% net margin).

Dividend & Returns

Yes, The Travelers Companies, Inc. (TRV) pays a dividend with a yield of 1.52%. This makes it attractive for income-focused investors.

The Travelers Companies, Inc. (TRV) has a return on equity (ROE) of 18.9%. This is reasonable for most industries.

Industry Metrics

The Travelers Companies, Inc. (TRV) has a combined ratio of 86.7%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...